glinide

Glinides are a class of oral antidiabetic drugs used to manage type 2 diabetes mellitus. They work by stimulating the pancreas to release more insulin, thereby lowering blood glucose levels. Glinides are typically taken shortly before meals to help control postprandial (after-meal) blood sugar spikes.

The primary mechanism of action for glinides involves binding to ATP-sensitive potassium channels on pancreatic beta cells. This binding closes the channels, leading to depolarization of the cell membrane. The depolarization then triggers the influx of calcium ions into the beta cell, which in turn promotes the secretion of insulin. This insulin release is glucose-dependent, meaning that glinides are more effective when blood glucose levels are elevated.

Common glinides include repaglinide and nateglinide. They are generally well-tolerated, with the most common side effect being hypoglycemia (low blood sugar), particularly if taken without a meal or if meal intake is insufficient. Other potential side effects can include gastrointestinal upset and upper respiratory tract infections. Glinides are often used in combination with other antidiabetic medications, such as metformin, to achieve better glycemic control. Their short duration of action makes them a useful option for patients who experience significant postprandial hyperglycemia.